| |
| Issue |
Title |
| |
| No 2 (2020) |
Clinical case of a paradoxical embolism that caused an acute myocardial infarction after deep vein thrombosis |
Abstract
PDF (Rus)
|
|
Yu. V. Larchikova, A. D. Ehrlikh, I. N. Smetanina, N. Yu. Zheltov |
| |
| No 1 (2020) |
Intracardiac thrombosis: frequency, risk factors and place of oral anticoagulants in treatment |
Abstract
PDF (Rus)
|
|
E. S. Kropacheva |
| |
| No 2 (2019) |
A CLINICAL CASE OF LYSIS OF THROMBUS IN THE LEFT ATRIAL APPENDAGE IN A PATIENT WITH ATRIAL FIBRILLATION PREVIOUSLY TREATED WITH WARFARIN |
Abstract
PDF (Rus)
|
|
T. A. Barbashina, O. Yu. Makhova |
| |
| No 1 (2019) |
PRASUGREL: FREQUENTLY ASKED QUESTIONS FROM PRACTITIONERS |
Abstract
PDF (Rus)
|
|
O. O. Shakhmatova, E. P. Panchenko |
| |
| No 2 (2018) |
IDARUCIZUMAB, A SPECIFIC REVERSAL AGENT FOR DABIGATRAN: THE PRESENT-DAY KNOWLEDGE |
Abstract
PDF (Rus)
|
|
Olga O. Shakhmatova |
| |
| No 1 (2018) |
HOW TO MINIMIZE THE BLEEDING RISK IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS: LESSONS DRAWN FROM RANDOMIZED TRIALS AND NEW CLINICAL GUIDELINES |
Abstract
PDF (Rus)
|
|
O. O. Shakhmatova, Е. P. Panchenko |
| |
| No 1 (2018) |
CLINICAL FACTORS AND ANTICOAGULATION LEVEL THAT DETERMINE THE SUDDEN LOSS OF KIDNEY FUNCTION IN PATIENTS LONG-TAKING WARFARIN (A 5-YEAR PROSPECTIVE, OBSERVATIONAL STUDY) |
Abstract
PDF (Rus)
|
|
E. S. Kropacheva, O. A. Zemlyanskaya, A. В. Dobrovolsky, Е. P. Panchenko |
| |
| No 1 (2018) |
IMPACT OF ABCB1 AND CES1 GENETIC POLYMORPHISMS ON TROUGH STEADY-STATE DABIGATRAN CONCENTRATIONS IN PATIENTS AFTER ENDOPROSTHESIS OF KNIFE JOIN |
Abstract
PDF (Rus)
|
|
D. A. Sychev, A. N. Levanov, T. V. Shelekhova, P. O. Bochkov, N. Р. Denisenko, K. A. Ryzhikova, K. В. Mirzaev, E. A. Grishina, M. A. Gavrilov |
| |
| No 2 (2017) |
THE EFFICACY OF LONG-TERM WARFARIN THERAPY: THE IMPACT ON THE INCIDENCE OF ISCHEMIC CEREBROVASCULAR DISORDERS AND CLINICAL PREDICTORS OF DEVELOPING SUCH DISORDERS. (Results of a prospective 10-year follow-up study) |
Abstract
PDF (Rus)
|
|
E. S. KROPACHEVA, O. A. ZEMLYANSKAYA, A. B. DOBROVOLSKY, E. P. PANCHENKO |
| |
| No 2 (2017) |
PLATELET TURNOVER AND ATHEROTHROMBOSIS |
Abstract
PDF (Rus)
|
|
A. V. MAZUROV |
| |
| No 2 (2017) |
НИЗКОМОЛЕКУЛЯРНЫЕ ГЕПАРИНЫ: ОРИГИНАЛЬНЫЕ ПРЕПАРАТЫ И ИХ БИОАНАЛОГИ - ВЫБОР В КЛИНИЧЕСКОЙ ПРАКТИКЕ. СЕМИНАР |
Abstract
PDF (Rus)
|
|
|
| |
| No 1 (2017) |
SAFETY OF LONG-TERM THERAPY WITH WARFARIN: HEMORRHAGE FREQUENCY AND CLINICAL PREDICTORS (results of a prospective 15-year follow-up) |
Abstract
PDF (Rus)
|
|
E. S. Kropacheva, O. A. Zemlyanskaya, E. P. Panchenko, A. B. Dobrovolsky, E. N. Krivosheeva |
| |
| No 2 (2016) |
ВОПРОСЫ БЕЗОПАСНОСТИ ТЕРАПИИ БОЛЬНЫХ С ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ |
Abstract
PDF (Rus)
|
|
, |
| |
| No 1 (2016) |
SAFETY ISSUES IN THE TREATMENT OF PATIENTS TAKING DABIGATRAN |
Abstract
PDF (Rus)
|
|
E. S. Kropacheva |
| |
| 1 - 14 of 14 Items |
|
